Heimdall Insights

Global Beta-Lactam and Beta-Lactamase Inhibitors Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Beta-Lactam and Beta-Lactamase Inhibitors Market was valued at $30.5 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 3.8% CAGR, to an estimated market size of $36.8 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The market encompasses beta-lactam antibiotics (including penicillins, cephalosporins, carbapenems, and monobactams) and beta-lactamase inhibitors co-administered to treat bacterial infections. The scope focuses on therapies that target bacterial cell wall synthesis while utilizing inhibitors to neutralize enzymes that cause antimicrobial resistance (AMR), primarily in hospital and critical care settings.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Beta-Lactam and Beta-Lactamase Inhibitors Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Asia-Pacific
  • Europe
  • Rest of World

Segments

  • Penicillins
  • Cephalosporins
  • Carbapenems
  • Beta-Lactamase Inhibitor Combinations
  • Monobactams